Abstract:Myricetin is a flavonoid with anticancer properties. This study aimed to formulate myricetin in the form of solid lipid nanoparticles (SLN), decorated with chitosan (CS) and active-targeted with folic acid (FA). After characterization, the in vitro release, cytotoxicity, antioxidant, and ability of the formulation to induce apoptosis using flow cytometry, fluorescent microscopy, and real-time qPCR were examined. Then in vivo anti-angiogenesis on chick chorioallantoic membrane (CAM) and antitumor activities on mice bearing tumor models were investigated. The present study showed that the size of 310 nm and zeta potential of + 30 mV were acceptable for oral administration. The Michaelis–Menten model fitted the drug release pattern with lag during 144 h of the study. The cytotoxicity assay showed that myricetin-SLN-CS-FA significantly killed cancer cells at the concentrations of 6.25, 12.5, 25, 50 and 100 μg/mL (* p < 0.05, ** p < 0.01, and *** p < 0.001). The highest level of apoptosis was shown at the concentration of 45 μg/ml in flow cytometry, and fluorescent studies. These results showed the anticancer properties of myricetin-SLN-CS-FA in a dose-dependent manner. The real-time results also indicated that the formulation exerted its cytotoxic effect by activating apoptosis genes. The DPPH, ABTS, and FRAP studies also demonstrated the significant antioxidant properties of the myricetin-SLN-CS-FA (* p < 0.05, ** p < 0.01, and *** p < 0.001). The anti-angiogenic activities of the formulations depicted in the CAM assay significantly decrease the number and length of the vessels (* p < 0.05, ** p < 0.01, and *** p < 0.001), and also affect VEGF and VEGFR, genes involved in angiogenesis (** p < 0.01, and *** p < 0.001). The antitumor studies indicated the statistically significant effects of myricetin-SLN-CS-FA on reducing tumor volume (* p < 0.05 and *** p < 0.001). The H&E staining of the liver and monitoring of the animal weights also indicated the safety of the formulation. The analysis of mRNA expression in liver and tumor demonstrated that myricetin-SLN-CS-FA exerts its antitumor activities by modulating the inflammatory and oxidative responses in the tissues.

Cytotoxic Effect of Novel Flammulina Velutipes Sterols and Its Oral Bioavailability Via Mixed Micellar Nanoformulation

Enhanced Oral Bioavailability and Tissue Distribution of a New Potential Anticancer Agent, Flammulina Velutipes Sterols, Through Liposomal Encapsulation

Enhanced Oral Bioavailability of a Sterol-Loaded Microemulsion Formulation of Flammulina Velutipes, a Potential Antitumor Drug

Effects of Polysaccharides from the Base of Flammulina Velutipes Stipe on Growth of Murine RAW264.7, B16F10 and L929 Cells.

Preparation and characterization of the myricetin-loaded solid lipid nanoparticles decorated with folic acid-bound chitosan and evaluation of its antitumor and anti-angiogenic activities in vitro and in vivo in mice bearing tumor models

Preparation and in vivo/in vitro evaluation of formononetin phospholipid/vitamin E TPGS micelles

Ergosterol-loaded Poly(lactide-Co-glycolide) Nanoparticles with Enhanced in Vitro Antitumor Activity and Oral Bioavailability

In Vitro Characterization and in Vivo Evaluation of Nanostructured Lipid Curcumin Carriers for Intragastric Administration

In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.

Novel Phospholipid-Based Labrasol Nanomicelles Loaded Flavonoids for Oral Delivery with Enhanced Penetration and Anti-Brain Tumor Efficiency.

Targeted Delivery of Curcumin to Tumors Via PEG-derivatized FTS-based Micellar System.

Turning Fluvastatin into a supramolecular immuno-sensitizer towards augmented tumor immunotherapy

Investigation of the Intracellular Oxidative Stress Amplification, Safety and Anti-Tumor Effect of a Kind of Novel Redox-Responsive Micelle

Preclinical activity of fluvastatin-loaded self-nanoemulsifying delivery system against breast cancer models: Emphasis on apoptosis

Proliposomes for Oral Delivery of Total Biflavonoids Extract from Selaginella Doederleinii: Formulation Development, Optimization, and in Vitro-in Vivo Characterization.

Preclinical Studies of N3-O-toluyl-fluorouracil-loaded Lipid-Based Nanosuspensions in H22-bearing Mice

Improved solubility, dissolution rate, and oral bioavailability of main biflavonoids from <i>Selaginella doederleinii</i> extract by amorphous solid dispersion

Anti-tumor activity and safety evaluation of fisetin-loaded methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) nanoparticles.

In Vitro Assessment of the Antioxidant and Anticancer Properties of Flammulina velutipes Stipe Extracts

The in vitro anti-tumor efficacy and the pharmacokinetics of N 3-O-toluyl-fluorouracil loaded nanosuspension (TFu-LNS)